# A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

> **NCT00465725** · PHASE1 · COMPLETED · sponsor: **Poniard Pharmaceuticals** · enrollment: 18 (estimated)

## Conditions studied

- Bladder Cancer
- Breast Cancer
- Colorectal Cancer
- Gastrointestinal Neoplasm
- Head and Neck Cancer
- Lung Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer

## Interventions

- **DRUG:** Picoplatin

## Key facts

- **NCT ID:** NCT00465725
- **Lead sponsor:** Poniard Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2009-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465725

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465725, "A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00465725. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*